Related Experiment Video

Updated: Jun 23, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.2K

Editorial: targeting liver biopsy in NAFLD-the need to expand our non-invasive tools. Authors' reply

Hannah P Kim1, Andrea R Mospan2, Michael W Fried2

  • 1University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Alimentary Pharmacology & Therapeutics
|December 15, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.3K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.4K

Related Experiment Videos

Last Updated: Jun 23, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.2K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.3K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.4K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Articles linked to this work by shared authors, journal, and citation graph.

Prognostic value of liver histology in steatotic liver disease: a systematic literature review and meta-analysis.

Journal of comparative effectiveness research·2026

Progression of MASH to cirrhosis, decompensation, and mortality, and the utility of NITs for detection and risk stratification.

Hepatology communications·2026

Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.

The American journal of gastroenterology·2026

Group-based telehealth stress management-lifestyle interventions are feasible for patients with chronic liver disease.

Hepatology communications·2025

The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH.

Alimentary pharmacology & therapeutics·2025

Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

The American journal of gastroenterology·2025

Medication Use and Risk of Microscopic Colitis: A Propensity-Matched Analysis of US Adults ≥ 50 Years (2014-2024).

Alimentary pharmacology & therapeutics·2026

Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta.

Alimentary pharmacology & therapeutics·2026

Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.

Alimentary pharmacology & therapeutics·2026

HLA-A*11:01 Identifies Patients at Risk for Persistent Viraemia and Advanced Fibrosis in HDV Infection.

Alimentary pharmacology & therapeutics·2026

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Alimentary pharmacology & therapeutics·2026

Risk of Coeliac Disease After Immune Checkpoint Inhibitor Exposure in Patients With Cancer.

Alimentary pharmacology & therapeutics·2026

Clinical translation of polymeric microneedles for bioactive nanovesicle delivery in hypertrophic scar remodeling.

Biomaterials science·2026

Factors Associated with the Presence of Non-Conformities in the Certification of Hospital Clinical Management Units in Andalusia.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2026

mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives.

Immunity, inflammation and disease·2026

Artificial Intelligence and Machine Learning in the Context of Hemophilia: A Scope Review.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

The polymeric nanovectors landscape for cancer immunotherapies towards advanced therapy medicinal products (ATMPs).

Acta pharmaceutica Sinica. B·2026

Advances of oral micro- and nanomedicines for modulating intestinal barriers in the treatment of intestinal diseases.

Acta pharmaceutica Sinica. B·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us